BioVectra Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioVectra Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10862
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioVectra Inc (BioVectra), a subsidiary of Mallinckrodt Plc, is a contract development and manufacturing organization that offers cGMP outsourcing solutions for intermediates and active pharmaceutical ingredients. The organization’s products include bioprocessing reagents, diagnostic reagents, molecular biology reagents and MPEG reagents. Its products are used in the therapeutic areas of cancer, kidney disease, multiple sclerosis, cardio-vascular disease, and other serious diseases. BioVectra’s capabilities include microbial fermentation, complex chemistry, high potency APIs, biologics, process and analytical development, and drug development. The organization serves pharmaceutical and biotechnology industries. It markets its products through a network of distributors across Austria, Switzerland, Australia, Japan, France, Italy, Israel, the UK and the US. BioVectra is headquartered in Charlottetown, Prince Edward Island, Canada.

BioVectra Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioVectra Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioVectra Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BioVectra Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Biovectra to Acquire Manufacturing Facility from Sepracor Canada 10
Partnerships 11
BioVectra Enters Into Co-Marketing Agreement With Quanta BioSciences 11
Licensing Agreements 12
BioVectra Enters into Licensing Agreement with TUBE Pharmaceuticals 12
Acquisition 13
Questcor Pharma Completes Acquisition Of BioVectra, Contract Manufacturing Company, For US$101 Million 13
BioVectra Inc – Key Competitors 14
BioVectra Inc – Key Employees 15
BioVectra Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
BioVectra Inc, Pharmaceuticals & Healthcare, Key Facts 2
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioVectra Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioVectra Inc, Deals By Therapy Area, 2012 to YTD 2018 8
BioVectra Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Biovectra to Acquire Manufacturing Facility from Sepracor Canada 10
BioVectra Enters Into Co-Marketing Agreement With Quanta BioSciences 11
BioVectra Enters into Licensing Agreement with TUBE Pharmaceuticals 12
Questcor Pharma Completes Acquisition Of BioVectra, Contract Manufacturing Company, For US$101 Million 13
BioVectra Inc, Key Competitors 14
BioVectra Inc, Key Employees 15

List of Figures
BioVectra Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioVectra Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[BioVectra Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The HallStar Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The HallStar Company Mergers an …
  • Luigi Lavazza S.p.A.:企業の戦略・SWOT・財務分析
    SummaryLuigi Lavazza S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • VitamFero SA:企業のM&A・提携動向(医療分野)
    Summary VitamFero SA (VitamFero) is a biotechnology company specializing in animal health. It designs, develops, registers and markets prophylatic agents such as vaccines and neonatal immunostimulants for the treatment of various infectious diseases using Toxo Mic1-3KO, a proprietary technology of t …
  • BioRelix, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BioRelix, Inc. Mergers and Acqu …
  • UMW Holdings Berhad (UMW):企業財務及び戦略的SWOT分析
    Summary UMW Holdings Berhad (UMW) is an automotive service provider that operates through its business including automotive, equipment, manufacturing and engineering, and oil and gas sectors. The company’s automotive unit manufacture, assembles, market and distributes vehicles. Its equipment unit of …
  • Yunnan Salt & Chemical Industry Co., Ltd (002053):企業概要、財務及び戦略的SWOT分析
    Summary Yunnan Salt & Chemical Industry Co., Ltd. (YSCC) is a chemical manufacturer. The company manufactures and sells salt and salt chemical products. It manufactures and markets table salt, industrial salt, dry acid, caustic soda, and polyvinyl chloride (PVC). YSCC produces bath salts, foot bath …
  • AgustaWestland N.V.:企業の戦略、SWOT、動向分析
    The report is a comprehensive, strategic resource on AgustaWestland N.V. providing key insights, analysis & information on the company. The initial sections provide a snapshot & overview on the business operations & market positioning of the company while the SWOT framework analyzes the core Strengt …
  • Lockheed Martin Australia Pty Ltd:企業の戦略・SWOT・財務情報
    Lockheed Martin Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Bow Energy Pty Ltd:企業の戦略的SWOT分析
    Bow Energy Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • SunPower Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SunPower Corporation Mergers an …
  • Santonia Energy, Inc. (formerly Fairborne Energy, Ltd.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Santonia Energy, Inc. (formerly …
  • Hanwha Chemical Corp (009830):企業の財務・戦略的SWOT分析
    Summary Hanwha Chemical Corp (Hanwha), a subsidiary of Hanwha Corp is a chemical company that manufactures, develops, and distributes basic industrial chemicals, general purpose plastic products, and other chemical products. The company's chemical products include inorganic compounds, PVC, polymers, …
  • NABsys Inc:企業のM&A・提携動向(医療分野)
    Summary NABsys Inc (NABsys) is a life sciences company that designs and develops semiconductor-based tools for genomic analysis. The company develops semiconductor based nanodetectors to analyze DNA molecules electronically. It provides platform to detect the positions of hybridized DNA probes and d …
  • Sound Oil plc (SOU):企業概要、財務及び戦略的SWOT分析
    Summary Sound Oil plc (Sound Oil) is an upstream oil and gas company. The company owns, manages and explores oil and gas producing assets. Its development projects include Rapagnano, Carita, and TorrenteAlvo. Sound Oil’s other projects include Colle Ginestre, Convento, Costa Del Sole, Fonte San Dami …
  • Sinolink Worldwide Holdings Limited:企業の戦略・SWOT・財務分析
    SummarySinolink Worldwide Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • International Data Group:企業概要及び戦略的SWOT分析
    International Data Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Aquila Resources Ltd:企業の戦略・SWOT・財務情報
    Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AXA SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' AXA SA Mergers and Acquisitions …
  • Silence Therapeutics Plc (SLN):企業財務及び戦略的SWOT分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a biotechnology company which develops and delivers RNA interference (RNAi) therapeutics for the treatment of serious diseases. The company's pipeline products include Atu027 and Atu111. Its Atu027 is developed for th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆